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The huge health burden accompanying obesity is not only attributable to inadequate dietary and 
sedentary lifestyle habits, since a predisposed genetic make-up and other putative determinants 
concerning easier weight gain and fat deposition have been reported. Thus, several investigations 
aiming to understand energy metabolism and body composition maintenance have been performed 
considering the participation of perinatal nutritional programming and epigenetic processes as well 
as inflammation phenomena. The Developmental Origins of Health and Disease (DOHaD) 
hypothesis and inheritance-oriented investigations concerning gene-nutrient interactions on energy 
homeostasis and metabolic cell functions have suggested that inflammation could be not only a co-
morbidity of obesity, but also an etiological agent. There are several examples about the role of 
nutritional interventions in pregnancy and lactation, such as caloric deprivation, protein restriction 
and excess fat feeding, which determine a cluster of disorders affecting energy efficiency in the 
offspring as well as different metabolic pathways, which are mediated by epigenetics encompassing 
the chromatin information mainly encrypted by DNA methylation patterns, histone covalent 
modifications and ncRNA or miRNA. Indeed, epigenetic mechanisms may be boosted or impaired 
by dietary and environmental factors in the mother, intergenerationally or transiently transmitted, 
and could be involved in the obesity and inflammation susceptibility in the offspring. The aims 
currently pursued are the early identification of epigenetic biomarkers concerned in individual’s 
disease susceptibility and the description of protocols for tailored dietary treatments/advises to 
counterbalance adverse epigenomic events. These approaches will allow diagnosis and prognosis 
implementation and will facilitate therapeutic strategies in a personalized “epigenomically-
modeled” manner to combat obesity and inflammation. 
 
Introduction 
 The vast health problems associated with fat deposition resulting in obesity is not only a laziness or 
gluttony trouble associated to inadequate sedentary lifestyles and unbalanced dietary habits, since in 
addition to a more susceptible genetic make-up to easier gain weight and fat deposition a number of 
recognized scientific evidences have theorized about the roles of other putative determinants(1). 
Thus, there are proofs that some other possible contributing factors to the obesity epidemic are 
microorganisms (infectobesity/microbioma), increased maternal age in human mothers, assortative 
mating plus a greater reproductive rates among couples with higher adiposity, sleep debits, 
hormonal and neurological disorders, undue weight gain associated to undesirable pharmacological 
side-effects, lesser variability of external weather conditions and  different intergenerational or 
intrauterine/epigenetic mediated effects(2). 
In this context, it has been claimed that parental nutrition previous to conception, maternal 
perinatal feeding and early postnatal dietary intake are involved in the onset of some chronic 
conditions accompanied by inflammatory manifestations such as obesity, diabetes, hypertension, 
dyslipaemia, etc at the life cycle, which has laid down the foundations of the offspring metabolic 
encoding(3). In addition to perinatal programming studies, several investigations aiming to 
understand energy metabolism and fuel utilization have been performed considering the interactions 
between genetics, inflammation phenomena and immunologically-related mediators(4). 
The term epigenetics was coined as a conceptual assumption for disentangling hither to 
undiscovered relationships between environmental settings and the genetic background to produce a 
given phenotypical outcome(5). Thus, an early definition for epigenetics involved "the study of the 
mechanisms of temporal and spatial control of gene activity describing pathways different from 
those directly attributable to the underlying DNA sequence and with an influence on the adaptive 
reaction of an organism” overcoming the usual legacy assigned to DNA(6). The "epigenetic code” 
encompass the chromatin information mainly encrypted by DNA involving methylation patterns in 
the nucleotide sequence, histone covalent modifications, miRNAs profiles and polycombs, which 
constitutes “the sum of the alterations to the chromatin template that collectively establish, 
modulate and propagate different patterns of gene expression and/or silencing from the same 
genome”(7). Therefore, epigenetics can provide some creative insights to understand genetic foetal 
programming, monozygotic twin differences, transgenerational outcomes and the onset of chronic 
diseases with associated inflammatory features such as obesity in the adult, which is requiring 
newer and elegant experimental models with a focus on phenomena affecting gene expression but 
not linked to the nucleotide sequence(8). 
The Developmental Origins of Health and Disease (DOHaD) hypothesis and nutritional 
programming. 
 The Developmental Origins of Health and Disease (DOHaD) hypothesis, which was initially based 
on epidemiological  approaches, is now receiving steady back-up and boosted support through 
intensive genetically-founded experimental research in both cell or animal models and through 
human genome-related findings(9). 
The pioneer finding that an association between poor foetal and infant growth with a higher risk 
of suffering metabolic syndrome features in adulthood has allowed to sustain the thrifty phenotype 
hypothesis, which points out that early inadequate nutrition induces insulin resistance(10). Additional 
studies conducted in other British Cohort(11), in Danish subjects born between 1936 and 1983(12), 
Dutch famine or Leningrad siege affected children(13) have been consistent with the possibility of  
developmentally-mediated origin of obesity(14). 
Furthermore, the National Children Study (NCS), the Southampton’s women survey (SWS), the 
Viva project and the Behavioural Perinatology Research Program  together with  other more 
recently launched investigations such as the Avon Longitudinal Study of Parents and Children 
(ALSPAC) are contributing to identify critical processes underlying the interactions between 
retarded foetal growth and development with adiposity related  outcomes and obesity features(15).  
Indeed, nutritional programming may explain the predisposition of some individuals to suffer 
non-communicable diseases in the adulthood linked to deprived in utero or infant development(16). 
Inheritance-oriented investigations concerning gene-nutrient interactions on energy homeostasis 
processes and metabolic cell functions is extending to all clinically chronic relevant diseases such as 
diabetes and cardiovascular events as well as to obesity and associated inflammatory features(17, 18). 
Also, some studies have identified that inflammation and transient infections could be not only a co-
morbidity of obesity and diabetes(19); but also an etiological agent(20, 21). 
The foetal or developmentally programmed genesis of adult sickness hypothesis settled that 
environmental factors and maternal lifestyles, particularly adverse nutritional disturbances, proceed 
in early life to drive the risks for the onset of metabolic diseases and excessive weight gain in later 
life stages(22). Indeed, maternal nutrition can program gene expression patterns to the embryo that 
persist into adulthood and may contribute to the appearance of typical metabolic syndrome features 
such as hypertension, insulin resistance, hyperlipemia and abdominal obesity(23). The parental 
conditions and lifestyles, which may involve maternal size/obesity, famine at perinatal periods, the 
use of nutritional supplements, alcohol or drug abuse as well the administration of therapeutical 
agents in this critical period may alter specific processes with an impact on embryonic, placental 
and foetal growth, organogenesis or regulatory set points for system functions affecting adiposity, 
where inflammatory and immunologically mediated processes may be involved(24). Interestingly, 
some of these epigenetically mediated signals may be not permanent but transient, which is of 
interest not only for prevention, but also as a target for developing future therapeutic focus(25).  
Unfavourable environmental cues coming from the mother such as psychological stress, 
infection, over-or undernutrition, smoking, neuroendocrine disruptors, trauma or diseases are 
signalled inputs negatively affecting the embryo, foetus or neonate(26). The adaptive responses may 
involve growth stunting or tissue remodelling with an impact on physiological functions and 
metabolism being the trade off and increased risk in later life(3). The characteristics of the 
programmed outcomes depend upon the insult or stimuli as well as on the timing of the exposure(27).  
Understanding the maternal regulation of foetal development and programming involves a 
knowledge about the genome, baseline maternal body composition, dietary and metabolic status, 
utero-placental blood flow and substrate transfer that may condition the nutrient balance and foetal 
malnutrition by inducing hypoxemia or metabolic changes (cortisol, insulin, nutrient oxidation) and 
altering body composition in the newborns(28). In this context; the term developmental plasticity has 
been used to define the aptitude of a unique genotype to produce a variable phenotype in response 
to changing environmental circumstances, even though may be neither adaptive nor prognostic as 
stated by the developmental programming theory(29), but struggling for resources which may 
envisage or forecast future metabolic scenarios in an effort to tune gene expression to generate a 
phenotype best adapted to the predictable afterwards environment(30). 
A number of mammal’s models have been developed to examine the potential processes and 
mechanisms involved in perinatal programming that depends on nutrition(31). The phenomena and 
manifestations ascribed to early nutritional programming have been explained through different 
mechanisms such as the involvement of the adipose tissue, the participation of different hormones 
and endocrine systems, enzymes, transcription factors and signalling mediators (glucocorticoids, 
insulin, PPAR family, adipokines,..), the regulation of specific nutrient related metabolic pathways 
(lipogenesis, glyconeogenesis,…), the control of neural networks affecting the appetite system 
(specific orexigenic/anorexigenic neuropeptides and the HPA axis) and the up/down feedback 
concerning the gene expression machinery and epigenetic marks(32, 33). 
The question if later obesity is in utero or early induced after birth has been repeatedly addressed 
and researched(34, 35). Thus, it seems that glucose, insulin and leptin coming from the mother’s blood 
or taken from the breast milk is of relevance for the persistent programming of food intake control 
at least in the rodent(36) as well as on obesity related peptides and hormones such as insulin(37). 
Furthermore, hormonal and metabolic signals acting during the perinatal period could alter the 
structure and functions concerning the fat-brain axis or adipogenic genes in the adipose tissue, that 
regulates the energy balance during later life(38). Alternatively, adverse intrauterine exposures may 
produce long-term changes in mRNA levels leading to a thrifty phenotype with changes affecting 
liver, muscle and renal anatomy and physiology(14) as well as longlasting changes in mitochondria 
that can be associated to obesity and insulin resistance in later life(39). Other mechanism that have 
been investigated in different animal models in order to clarify the role of the perinatal feeding on 
tissue structure have revealed an important impact of the maternal diet on proliferation and 
differentiation processes in the pancreas and in the brain involving an overexposure to 
glucocorticoids mediated by a reduced activity of the placental 11-beta hydrosteroid 
dehydrogenase(33). Also, a maternal obese condition influences foetal growth and body composition 
with implications in the future offspring health depending on the genetic background, the 
intrauterine metabolic environment and the generated maternal metabolites(22). Thus, a mild 
maternal overnutrition led to increased adiposity, glucose intolerance and altered brain appetite 
regulators in offspring(40), while food-deprived dams may transfer to the offspring patterns of 
increased hepatic gluconeogenesis, enhanced release and impaired oxidation of fatty acids from 
adipocytes, resistance to ketosis and changes in glucose uptake mediated for an increased insulin 
receptor expression(10). On the other hand, intrauterine growth restriction due to an induced 
perinatal impaired uteroplacental function or nutrient deficiency have been linked to lower leptin, 
normal or lower adiponeptin and higher ghrelin as well as visfatin levels, while contradictory results 
have been reported concerning apelin/resistin and other pro-inflammatory markers such as TNF-alfa 
and Il-6(41). Interestingly, maternal perinatal undernutrition attenuates T-Cell function in adult male 
rat offspring(42). 
Finally epigenetic marks affecting a number of  genes regulating energy metabolism, 
adipogenesis or inflammatory processes are providing new clues to understand the relationships 
between  nutritional programming and obesity in the adulthood(24, 43). 
Despite the general acceptance of the DOHaD hypothesis, the terms of such proposal  has not 
been always demonstrated in epidemiological surveys, while that some inconsistent results have 
been reported in animal models(26), a systematic error in interpreting experimental data and a 
publication bias due to missing information is not rule out. 
 
Animal models and epigenetic regulation   
 There is a number of experimental interventions in animals about the role of nutrition in pregnancy 
and lactation such as caloric deprivation, protein restriction and excess fat feeding(33). Such 
investigations have proven a cluster of disorders affecting energy efficiency as well as the 
impairment of  different metabolic pathways and adverse predisposition for suffering cardiovascular 
diseases, glucose intolerance and obesity on the offspring(8); and unfavoutable inflammatory 
interactions(44). 
A loss of diurnal variation in heart rate and blood pressure in adulthood has resulted from 
maternal undernutrition followed by postnatal overnutrition in rodents, while hyperphagia resulting 
from perturbed development of the hypothalamic circuitry devoted to food intake control may 
contribute to overweight and developmental changes in fat cell precursors(45). On the other hand, 
maternal obesity has an effect on pancreatic beta cells inducing a higher risk of diabetes(46). The 
mitochondrial DNA content of the liver and skeletal muscle were reduced in fetal and early 
postnatal undernourished animals even when balanced nutrition was provided after weaning, which 
were accompanied by a decrease in mitochondrial DNA-encoded gene expression indicating that 
poor nutrition in early life causes long-lasting changes in mitochondria that may contribute to the 
development of insulin resistance in later life(39). The adverse effects of a in utero low protein 
dietary intake have been associated with diabetes(47), increased systolic blood pressure(48), altered 
glucose tolerance(48), hyperisulemia and reduced insulin signalling protein expression(49). Also, a 
reduced maternal protein consumption during pregnancy and lactation has window of exposure and 
sex-specific effects on offspring growth, adiposity, appetite, glucose utilization and circulating 
leptin(50). A programming of hepatic insulin-sensitive enzymes in the offspring of rat dams fed a 
protein-restricted diet was found, where glucokinase activity decreased (approximately 50%), 
whereas phosphoenolpyruvate carboxykinase (PEPCK) activity increased (approximately 100%) 
with parallel changes in gene expression in both enzymes(51). Indeed, the understanding of genetic 
and epigenetic contributions to human nutrition and health is contributing to translate basic biology 
into clinical applications(1, 52) concerning perinatal nutrition and disease in the adulthood. 
Three genomic targets have been involved in the modulation of the gene expression changes: 
epigenetic marks at the promoter regions of some epiobesigenes , transposable elements that lie 
adjacent to genes with metastable epialleles and the regulation of imprinted genes(53). In this 
context, epigenetic studies are contributing to unravel some putatively hidden phenomena that are 
not being explained by the accomplishment of the Human Genome Project in relation to obesity(54). 
In the last years, different examples of dynamical changes in DNA methylation patterns, histone 
covalent modifications and the involvement of non coding RNAs due to the restriction or 
supplementation with different nutrients have been reported(4, 24) as well as related to obesity(55), 
Thus, the methylation pattern of the leptin promoter in adipocytes is affected by a high fat intake in 
rats following an inverse trend to  body weight changes(56), while weight gain induced by an 
isocaloric pair-fed high fat diet produced a nutriepigenetic outcome on FASN and NDUFB6 gene 
promoters(57). 
Interestingly, maternal supraphysiological methyl group (folate, cobalamine, choline and 
betaine) or genistein  supply throughout pregnancy modified DNA methylation of some key 
metabolic genes, with implications in adiposity(58, 59), while protein restriction of pregnant rats 
induced DNA hypomethylation in the glucocorticoid receptor and peroxisomal proliferator-
activated receptor-α genes in the liver of the newborns, which was prevented by folic acid 
supplementation(60). Also, it has been found that a chronic high-fat diet in fathers epigenetically 
programs β-cell dysfunction in female rat offspring(61). These findings are  in agreement with 
previous observations suggesting that transgenerational epigenetic inheritance may be sex 
dependent for specific traits(62, 63).  
In addition to changes in methylation patterns, epigenetic transfer may involve histone 
modifications and microRNA mediated mechanisms(64). Thus, an energy-dense maternal diet 
driving to obesity epigenetically impairs fetal chromatin structure in primates via covalent 
modifications on histones(65), while a role for microRNA in the alternative expression of IGF-2 in 
fetal livers from high-fat fed dams has been reported(66, 67). 
All these data and experiments strongly suggest that epigenetic mechanisms may be boosted or 
impaired by dietary and environmental factors in the gestating mother and could be involved in 
obesity susceptibility in the offspring(9, 35). 
 
Obesity, inflammation and epigenetics 
 Inflammation is a protective complex biological response mounted by tissues to combat injurious 
stimuli in order to maintain cell homeostasis(68),  which include host defence, tissue remodelling and 
metabolic changes and involve multiple mechanisms such as the contribution of  immune cells 
(recruitment and activation of leukocytes, granulocytes, monocytes, B- T lymphocytes and dendritic 
cells), the involvement of different mediators (interleukins, TNF-alfa, leptin, adipokynes….) or the 
regulation of signalling pathways (insulin, glucose, lipids…) and eventually the epigenetic 
regulation of the expression of some related genes(4, 69). Indeed, many important risk factors for 
obesity (overnutrition, low dietary fibre intake, sedentary lifestyles, sleep debts, neuroendocrine  
status or genetic make-up) have been found to be implicated in local or low-grade systemic 
inflammation(19). Thus, an excessive adiposity  has been seen either as a cause or as a consequence 
of chronic inflammatory disorders and epimutations(20, 23). Interestingly, inflammatory signaling as 
mediator of epigenetic modulation in tissue-specific chronic inflammation has been identified(70). 
One of the challenges for investigators researching in the epigenomics field is identifying and 
characterizing the epigenetic marks and those stimuli modulating the expression of some specific 
genes (epiobesogenes) in pathways involving obesity/body weight homeostasis and energy balance 
processes such as adipogenesis, inflammation, appetite, insulin signalling, thermogenesis or 
macronutrient turnover(24). Indeed, a bioinformatics analysis of promoter regions for the search of 
epigenetic biomarkers of obesity, have identified affected methylation patterns on several obesity-
related genes such as FGF2, PTEN, CDKN1A and ESR1, implicated in adipogenesis,  
SOCS1/SOCS3, in inflammation, and COX7A1 LPL, CAV1 and IGFBP3, in intermediate 
metabolism and insulin signalling(71). The characterization of those individuals that at an early age 
could present changes in the methylation profiles of specific genes could help to predict their 
susceptibility to later develop obesity, which may allow to prevent and follow-up its progress, as 
well as to research and develop newer therapeutic approaches. Thus, from approximately 760 
human genes under putative epigenetic regulation (http://www.ncbi.nlm.nih.gov/sites/entrez), 
about 20% of them, defined as epiobesigenic genes, could be associated to obesity(72). The 
knowledge of the modification of their methylation patterns due to different dietary factors, age, 
inflammation or some of the physiological aspects surrounding overweightness, could be crucial to 
investigate the role of these mechanisms in the prevention, onset and therapy of obesity as well the 
reversibility/stability of the epigenetic code and the involvement of specific enzymes (methylases, 
acetylases…) is of interest(54).  
Signal-specific inflammatory mechanisms epigenetically-mediated may operate through 
transcription factors (NFkB family), kinases (IKK-related kinases, MSK, PKA, PI3k, AKT…), the 
endoplasmic reticulum (calcium), biochemical activation of DNA methyltransferases (DMT, 
DNMT) and histone-modifier enzymes ( HDAC/HAT, HMT, SIRT...), changes in cellular pools of 
acetylCoA, NAD or methyl donors, which are sensible to oxidative stress, hyper- or hypoglycemia, 
fatty acids load, and be activated or inhibited by overnutrition(67, 73). Furthermore, in addition  to 
epigenetic processes involving methylation marks, histone modifications, also noncoding RNAs are 
susceptible to dynamic inflammatory control(4). 
The concept of epigenetic regulation is gradually being recognized as an important factor in 
inflammatory related events such as obesity, diabetes and cardiovascular diseases(74). Gene 
silencing in severe systemic inflammation have been associated to the reprogramming of acute pro-
inflammatory genes, the intervention of the NFkB and compartmentalization of the epigenetic 
process(75). In this context, the impact of inflammation on global  DNA methylation has been 
demonstrated in chronic kidney disease, while an epigenetic regulation of high-glucose induced 
proinflammatory cytokine production in monocytes have been described for the polyphenol 
curcumin involving NFkB(76). On the other hand, histone deacetylase inhibitors (HDACi) are 
emerging as possible epigenetic modulators of gene expression controlling the inflammatory 
response in some circumstances(77). Also, an increased expression of DNA methyltransferase3a in 
obese adipose tissue has been reported(78), while the methylation of polycomb target genes may be 
mediated by inflammation(79). Furthermore, redox modulation of chromatin remodeling may have 
an effect on hystone acetylation/deacetylation modulating the expression of pro-.inflammatory 
genes(80). Finally, enhanced levels of micro RNA125b are associated to increased to specific 
inflammatory gene expression on db/db mice(81). A relevant locus-specific DNA methylation 
affecting inflammatory processes have been reported for at least the following genes: leptin (LEP), 
superoxide dismutase (SOD), glucorticoid receptor (GR), peroxisome proliferator-activated receptor 
(PPAR), tumor necrosis factor-alfa (TNF-a), endothelial and inducible nitric oxide synthase 
(eNOS/iNOS) and hypoxia-inducible factor (HIF), whose epigenetic machinery understanding will 
contribute to the inflammation management and associated disorders such as obesity(4). 
Obesity-associated adipose tissue enlargement is often associated to an elevated secretion of 
proinflammatory adipokines such as leptin and cytokines such as TNF-alpha, whose epigenetic 
regulation has emerged as a potentially important gene expression determinant(82). Thus, at baseline, 
obese women with better response to an energy restricted dietary intervention  designed to induce 
weight loss showed lower promoter methylation levels of leptin and TNF-alpha than the non-
responder group, which  suggest that leptin and TNF-alpha methylation levels could be used as 
epigenetic biomarkers concerning the response to a low-calorie diet. Indeed, the methylation profile 
could help to predict the susceptibility to weight loss as well as some comorbidities such as 
hypertension or type 2 diabetes(83, 84). Additional investigations concerning the interactions between 
obesity and inflammation under a epigenetic perspective have allowed to identify different CpG 
sites from WT1 and ATP10A genes, which were significantly modified as a result of an 
hypocaloric-diet-induced weight loss in humans by altering  DNA methylation status of  these 
specific genes indirectly related with inflammatory processes, suggesting that  baseline DNA 
methylation patterns may be used as a prognostic epigenetic markers that could help to predict 
weight loss(85). 
Summing up, there is growing evidence suggesting that interindividual differences in obesity 
susceptibility depend not only in the DNA sequence (genetics) but also on epigenetic factors 
affecting gene expression such as DNA methylation, covalent histone modifications, chromatin 
folding and the regulatory actions of miRNAs and polycombs complexes, in which inflammatory 
phenomena may be involved. Thus, epigenetics is providing novel insights on cellular identity, stem 
cell flexibility, tissue regeneration, tumorigenesis, and aging and to understand monozygotic twin 
differences and interestingly the onset of chronic diseases in the adult such as obesity. The 
following aims are presently pursued in the ground of obesity and epigenomics: the early 
identification of epigenetic biomarkers concerned in individual’s disease susceptibility and the 
description of weight lowering protocols for tailored dietary treatments/advises to avoid/neutralize 
likely adverse epigenomic events. Other questions that remain to be answered are to understand the 
regulation of epigenomic fenomena, the period(s) for intervention, the key nutritional factors and 
doses, which will allow diagnosis and prognosis implementation and will facilitate 
Preventive/curative strategies in a personalized “epigenomically” based manner to combat obesity. 
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